Lexaria Bioscience hires advisory firm, receives 4 new patents
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Lexaria Bioscience Corp. Provides Strategic Update
October 9, 2025 9:20 AM EDTStrategic Business Development Advisory Firm Engaged To Support New Business Development Activities
Lexaria Awarded 4 New Patents
KELOWNA, BC / ACCESS Newswire / October 9, 2025 / Lexaria Bioscience Corp. (NASDAQ: LEXX)(NASDAQ: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provide the following strategic business update.
For several years, Lexaria has been validating the applicability of its patented DehydraTECH technology across a number of... More
